CI

At a glance

ClinicalIndex Comparison Record
Phase 4Completed· 397 enrolled
Drug / intervention
Sertraline +3 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00282828
NCT00282828Phase 4Completed
CompareCT.gov

Improving Outcomes in Pharmacotherapy of Social Phobia

Massachusetts General Hospital·interventional·Posted Jan 27, 2006·Updated Oct 14, 2013

In Brief

A Phase 4 clinical trial evaluating Sertraline, Venlafaxine, and 2 other interventions for Social Phobia. Completed, enrolled 397 participants across 3 sites in 2 countries.

Detailed Summary

This study will compare the effectiveness of either adding clonazepam or placebo to standard treatment or switching to venlafaxine in treating generalized social anxiety disorder in individuals who have not responded to treatment with sertraline.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsSocial Phobia
CountriesCanada, United States
CollaboratorsNational Institute of Mental Health (NIMH)

Timeline

Phase 4CompletedFinished
2006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedJan 27, 2006
Enrollment StartMar 1, 2006
Primary CompletionDec 1, 2011
TodayJul 2, 2026
Enrollment to primary: 5.8 yearsPosted 20.4 years ago

Interventions

Sertralinedrug

Venlafaxinedrug

Placebodrug

Clonazepamdrug